62.44 F
New York
May 23, 2022

MRCH1

AstraZeneca says EU regulator approves COVID shot as booster

Reuters
May 23 (Reuters) – Drugmaker AstraZeneca (AZN.L) said on Monday its COVID-19 vaccine, Vaxzevria, has been approved in the European Union by the bloc’s drugs regulator as a third-dose booster in adults following a committee endorsement last week. The vaccine can now be used as a booster following the two-dose......

Blow to Roche’s cancer immunotherapy prospects as 2nd trial fails

Reuters
The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo Register now for FREE unlimited access to Reuters.com Register Drug candidate tiragolumab previously flunked trial in March Anti-TIGIT class of drugs has attracted several rivals Roche says trial will continue......

Pfizer to pay $11.6 bln for Biohaven to tap migraine market

Reuters
May 10 (Reuters) – Pfizer Inc (PFE.N) said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co (BHVN.N), making a big bet its ability to boost sales of the top-selling pill in a new class of migraine drugs. The boards of both companies have approved the......

Omicron as severe as previous COVID variants, large study finds

Reuters
A woman takes a coronavirus disease (COVID-19) test at a pop-up testing site as the Omicron coronavirus variant continues to spread in Manhattan, New York City, U.S., December 27, 2021. REUTERS/Jeenah Moon Register now for FREE unlimited access to Reuters.com Register May 5 (Reuters) – The Omicron variant of the......

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Reuters
A vial labelled “Moderna COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Register now for FREE unlimited access to Reuters.com Register WASHINGTON, May 1 (Reuters) – Moderna Inc’s (MRNA.O) chief medical officer said on Sunday the company’s vaccine for children under 6 years old......

All Blue Capital in $773 mln bid for Zymeworks

Reuters
April 28 (Reuters) – Investment firm All Blue Capital has approached Zymeworks Inc (ZYME.N), a developer of antibody therapies for cancer, with a $773 million acquisition offer. In a regulatory filing late on Thursday, All Blue said it had made a non-binding offer for $10.50 per share in cash, which......

Britain gives first European approval to Valneva COVID shot

Reuters
Shares rally more than 20% UK govt cancelled plans to buy shot last year EU drug regulator assessing shot for possible approval LONDON/PARIS, April 14 (Reuters) – Britain approved Valneva’s (VLS.PA) COVID-19 vaccine on Thursday, becoming the first European country to clear the use of the French firm’s shot in......

U.S. FDA aims to decide on strain selection for COVID boosters by June

Reuters
April 6 (Reuters) – The U.S. Food and Drug Administration said it is aiming to come up with a decision on coronavirus strain selection for the composition of future COVID-19 boosters by June, as a panel of its advisers met on Wednesday to discuss the issue. “We should be thinking......

U.S. FDA advisers to discuss additional COVID vaccine shots, booster design

Reuters
People wait in line to be tested for coronavirus disease (COVID-19) at the Tower Theatre in Oklahoma City, Oklahoma, U.S., January 11, 2022. REUTERS/Nick Oxford Register now for FREE unlimited access to Reuters.com Register April 4 (Reuters) – The U.S. Food and Drug Administration’s expert advisers will discuss the timing......

U.S. FDA considering additional round of boosters in the fall -official

Reuters
WASHINGTON, March 29 (Reuters) – The U.S. Food and Drug Administration will weigh the benefits of authorizing a round of boosters of either the Pfizer/BioNTech or Moderna COVID-19 vaccine to a broader population in the fall, a top official said on Tuesday. The agency authorized on Tuesday a second booster......

Tesla, Overstock.com, Rackspace Technology, Palo Alto Networks

Reuters
U.S. stocks slipped on Wednesay after giving up all of the opening gains as reports of cyberattacks on several Ukrainian state websites added to fears about escalating tensions with Russia. At 10:42 ET, the Dow Jones Industrial Average (.DJI) was down 0.21% at 33,525.02. The S&P 500 (.SPX) was down......

Canada approves Novavax’s COVID-19 vaccine for adults

Reuters
Vials labelled “VACCINE Coronavirus COVID-19” and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic Register now for FREE unlimited access to Reuters.com Register Feb 17 (Reuters) – Canada on Thursday approved Novavax Inc’s (NVAX.O) COVID-19 vaccine for people......

The S&P 500 closes lower as Russia-Ukraine tensions heat up

Reuters
NEW YORK, Feb 14 (Reuters) – The S&P 500 index (.SPX) ended weaker on Monday, partly recovering from a steep late-afternoon sell-off, as U.S. plans to close its Kyiv embassy in Ukraine sent simmering geopolitical tensions to a boil. All three major U.S. stock indexes dropped sharply after U.S. Secretary......

Germans pin hopes on Novavax moving the needle among anti-vaxxers

Reuters
BERLIN, Feb 13 (Reuters) – Benedikt Richter, a 40-year-old teacher in the southwest German city of Kaiserslautern, long held out against getting vaccinated against COVID-19. He felt uneasy about the novelty of the mRNA technology used in two of the most commonly administered shots. It did not help that his......

S.Korea turns to self-treatment as Omicron fuels COVID surge

Reuters
SEOUL, Feb 10 (Reuters) – South Korea said on Thursday patients with mild coronavirus symptoms will have to treat themselves, aiming to free up medical resources for more serious cases, as new infections hit a fresh high because of the fast spreading Omicron variant. South Korea has largely been a......

Omicron-specific booster may not be needed, U.S. monkey study finds

Reuters
Test tube labelled “COVID-19 Omicron variant test positive” is seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic Register now for FREE unlimited access to Reuters.com Register CHICAGO, Feb 4 (Reuters) – A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster......

In world first, S.Africa’s Afrigen makes mRNA COVID vaccine using Moderna data

Reuters
CAPE TOWN, Feb 3 (Reuters) – South Africa’s Afrigen Biologics has used the publicly available sequence of Moderna Inc’s (MRNA.O) mRNA COVID-19 vaccine to make its own version of the shot, which could be tested in humans before the end of this year, Afrigen’s top executive said on Thursday. The......

J&J expects COVID vaccine sales to jump as much as 46% in 2022

Reuters
People pose with syringe with needle in front of displayed Johnson & Johnson logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Jan 25 (Reuters) – Johnson & Johnson (JNJ.N) on Tuesday forecast as much as $3.5 billion in sales......

U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments

Reuters
Jan 24 (Reuters) – The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron (REGN.O) and Eli Lilly (LLY.N) to limit their use, as the drugs are unlikely to work against the Omicron coronavirus variant. The Food and Drug Administration (FDA) said the......

Djokovic bets on a COVID cure as he quests for tennis history

Reuters
Serbian tennis player Novak Djokovic arrives at Nikola Tesla Airport, after the Australian Federal Court upheld a government decision to cancel his visa to play in the Australian Open, in Belgrade, Serbia January 17, 2022. REUTERS/Christopher Pike Register now for FREE unlimited access to Reuters.com Register COPENHAGEN, Jan 19 (Reuters)......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More